161.38USD-0.34%Mkt Cap: 24.42B $P/E: 29.291d ago
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and arr…
Indicators:|
Key Statistics
Company
Market Cap24.42B $
Enterprise Value25.89B $
Revenue (TTM)4.39B $
Gross Profit2.87B $
Net Income (TTM)850.00M $
Revenue/Share28.62 USD
Last Price161.38 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees8.6K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)29.29
P/E (Forward)27.33
PEG2.84
EV/EBITDA22.41
EV/Revenue5.89
P/S5.58
P/B9.20
EPS (TTM)5.51
EPS (Forward)5.92
52W Range
88.0082% of range177.22
52W High177.22 USD
52W Low88.00 USD
Profitability
Gross Margin66.08%
Oper. Margin18.33%
EBITDA Margin26.29%
Profit Margin19.57%
ROE31.22%
ROA12.79%
Growth
Revenue Growth4.80%
Earnings Growth6.10%
Cash Flow & Leverage
Operating CF1.08B $
CapEx (TTM)148.00M $
FCF Margin19.25%
FCF Yield3.46%
Net Debt1.39B $
Net Debt/EBITDA1.20
Balance Sheet
Debt/Equity0.94
Current Ratio1.75
Quick Ratio1.23
Book Value/Sh17.61 USD
Cash/Share7.634 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1028:1000
Split DateJun 25, 2024
Analyst Consensus
Rating2.3 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)148.56 USD
Upside (mean)-7.9%
Target Range95.00 USD – 185.00 USD
$95.00-7.9% to mean$185.00
# Analysts18
Ownership
Shares Out.151.30M
Float148.03M
Insiders0.20%
Institutions106.53%
Short Interest
Short Ratio4.2d
Short % Float8.34%
Short % Out.5.10%
Shares Short7.72M
Short (prev mo.)6.55M
Technical
SMA 50144.57 (+11.6%)
SMA 200126.71 (+27.4%)
Beta1.49
S&P 52W Chg24.49%
Avg Vol (30d)1.72M
Avg Vol (10d)1.86M
Technical Indicators
RSI (14)56.2
MACD4.9441
MACD Signal6.0832
MACD Hist.-1.1391
BB Upper174.54 USD
BB Middle160.59 USD
BB Lower146.64 USD
BB Width17.37%
ATR (14)6.218 USD
Vol Ratio (20d)1.06x